Skip to main content

Table 1 Clinico-pathological data of 28 LAC patients used for the generation of expression profiles.

From: Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study

Code

Age

Sex

Grade

T

N

M

R

Smoker

LAC_19

58

M

2

2

2

0

0

yes

LAC_20

59

F

3

2

1

0

1

yes

LAC_21

75

M

2

2

0

0

0

yes

LAC_22

60

F

2

1

2

0

0

yes

LAC_23

47

F

3

2

1

0

1

n.a.

LAC_24

61

M

2

4

2

0

0

yes

LAC_25

64

F

3

2

2

1

0

yes

LAC_26

70

M

2

1

0

0

0

yes

LAC_36

72

F

3

2

2

0

0

yes

LAC_37

67

F

2

2

0

0

0

yes

LAC_38

82

M

2

4

2

0

0

yes

LAC_39

69

M

1

2

2

0

0

yes

LAC_40

83

F

1

1

0

0

0

yes

LAC_41

51

F

2

2

0

0

0

yes

LAC_42

78

F

3

2

0

0

0

no

LAC_43

59

F

2

4

2

0

0

yes

LAC_45

69

M

2

2

0

0

0

yes

LAC_47

56

M

2

1

2

0

0

yes

LAC_49

72

M

3

2

2

0

0

yes

LAC_51

65

M

3

2

2

0

0

yes

LAC_52

70

F

2

2

1

0

0

yes

LAC_53

62

F

3

2

1

0

0

yes

LAC_54

54

F

2

1

0

0

0

yes

LAC_55

77

F

2

2

0

0

0

yes

LAC_56

67

M

3

2

0

0

0

yes

LAC_57

73

M

2

1

0

0

0

yes

LAC_58

56

M

3

2

1

X

0

n.a.

LAC_61

76

F

1

2

0

X

0

n.a.

  1. Classification according to WHO and TNM-Classification (6thedition 2002). LAC = lung adenocarcinoma; Age = age at operation; F = female; M = male; T = tumor stage; N = absence (0), presence of ipsilateral peribronchial and/or ipsilateral hilar lymph node metastasis (1) or ipsilateral mediastinal and/or subcarinal lymph node metastasis (2); M = absence (0) or presence (1) of distant metastasis; R = absence (0) or presence (1) of residual tumor; X = classification could not be assessed; n.a. = data not available.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us